PeptideDB

PKN3-IN-1

CAS: 2361545-75-5 F: C18H17IN2O3 W: 436.24

PKN3-IN-1 (compound 16) inhibitsPKN3 (serine/threonine protein kinase 3) and GAK (cyclin G-associated kinase) with IC50
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity PKN3-IN-1 (compound 16) inhibits PKN3 (serine/threonine protein kinase 3) and GAK (cyclin G-associated kinase) with IC50 of 0.014 μM and Ki of 0.0044 μM respectively. PKN3-IN-1 is a potential tool compound to study the cell biology of PKN3 and its role in pancreatic and prostate cancer and T-cell acute lymphoblastic leukemia [1].
Invitro PKN3-IN-1 (1 μM,48 h) 在 HEK 293 细胞中抑制 PKN3,IC50 为 0.014 μM [1].PKN3-IN-1 (1 μM,24 h) 在 HEK 293 细胞中抑制 GAK,Ki 为 0.0044 μM [2].PKN3-IN-1 (1.3 μM) 在 5 μM 以下具有细胞内靶向结合能力[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> PKN3-IN-1 相关抗体:
CAS 2361545-75-5
Formula C18H17IN2O3
Molar Mass 436.24
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Asquith CRM, et al. Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype. ChemMedChem. 2022 Jun 20;17(12):e202200161. [2]. Asquith CRM, et al. Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase. ChemMedChem. 2018 Jan 8;13(1):48-66.